John Harris is a seasoned investor, entrepreneur, executive, and corporate director with three decades of experience starting, developing, and directing early-stage life sciences and technology companies.
John’s board positions include Foresight Mental Health, Cadence Neuroscience, BlueNote Therapeutics, and HerMD. John is an empathetic, hands-on director who brings expertise in strategic analysis, leadership, creativity, concept development, product development, marketing, and finance.
Prior to JAZZ, John was the founder, president, and CEO of NeuroVista, a Seattle-based medical device company pioneering new technologies for the management and treatment of epilepsy. John was also a founder of Northstar Neuroscience, which went public in 2006 and was subsequently acquired by St. Jude Medical. Previous to that, John was a founder of Heartstream, a company that revolutionized the treatment of sudden cardiac arrest with uniquely designed external defibrillators that remain the global market leader and can be found in airports, sports arenas, public buildings, and many other locations. Heartstream went public in 1996 and was subsequently acquired by Hewlett-Packard.
John holds an engineering degree from Stanford, and an M.B.A. from Northwestern. He is passionate about fly-fishing and the outdoors, and lives with his wife in Medina, Washington.
